*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>2-[(1S,2S)-1-Ethyl-2-benzyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-</strong> is a complex chiral intermediate primarily utilized in the synthesis of advanced pharmaceutical agents. Its core manufacturing process involves asymmetric hydrogenation and selective etherification to ensure stereochemical purity.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Synthesis:</strong> Serves as a critical scaffold for developing novel antihypertensive or cardiovascular therapeutics.</li>
<li><strong>R&D Laboratories:</strong> Employed in structure-activity relationship (SAR) studies to optimize drug efficacy and metabolic stability.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage:</strong> Maintain under inert atmosphere at temperatures below -20°C to prevent hydrolysis and racemization.</li>
<li><strong>Safety:</strong> Handle with appropriate PPE due to potential irritant properties; strictly adhere to GMP protocols during clinical scale-up.</li>
</ul>